Abstract 1742: Molecular characterization of CRPC pathogenesis and development of a novel anti-PSMA-drug conjugated hybrid nanoparticle therapy with reduced cellular toxicity - KIVIRID

Abstract 1742: Molecular characterization of CRPC pathogenesis and development of a novel anti-PSMA-drug conjugated hybrid nanoparticle therapy with reduced cellular toxicity

Authors: Thangavel Chellappagounder

Published: 2022-06-15

DOI: 10.1158/1538-7445.am2022-1742

Source: Full article

Abstract

Abstract